Alerts will be sent to your verified email
Verify EmailAPLLTD
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Alembic Pharmaceuticals Limited is a top pharmaceutical company in India known for its expertise in India Formulations, International Generics, and Active Pharmaceutical Ingredients. It excels in oncology, injectables, and ophthalmology.
Alembic Pharma major competitors are Astrazeneca Pharma I, Jubilant Pharmova, Caplin Point Lab, Natco Pharma, Eris Lifesciences, Pfizer, Wockhardt.
Market Cap of Alembic Pharma is ₹18,836 Crs.
While the median market cap of its peers are ₹20,728 Crs.
Alembic Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Alembic Pharma is 6.84 and is ranked 5 out of its 8 competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | ||||||||||||
Investor Presentation | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | |||
Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | Jun Sep Dec | Jun Sep Dec | Jun Dec | ||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|